134729-13-8
中文名称 | 134729-13-8 |
---|---|
中文同义词 | 化合物 T10032;化合物COX-2-IN-2 |
英文名称 | 1-(4-fluorophenyl)-5-[4-(methylsulfonyl)phenyl]-pyrazole-3-carbonitrile |
英文同义词 | 1-(4-fluorophenyl)-5-[4-(methylsulfonyl)phenyl]-pyrazole-3-carbonitrile;COX-2-IN-2;1H-Pyrazole-3-carbonitrile, 1-(4-fluorophenyl)-5-[4-(methylsulfonyl)phenyl]-;COX2IN2,COX 2 IN 2 |
CAS号 | 134729-13-8 |
分子式 | C17H12FN3O2S |
分子量 | 341.3594832 |
EINECS号 | |
相关类别 | |
Mol文件 | 134729-13-8.mol |
结构式 |
134729-13-8 性质
沸点 | 563.6±50.0 °C(Predicted) |
---|---|
密度 | 1.33±0.1 g/cm3(Predicted) |
储存条件 | Store at -20°C |
溶解度 | 溶于二甲基亚砜 |
酸度系数(pKa) | -5.89±0.10(Predicted) |
形态 | 固体 |
颜色 | 米白色至浅黄色 |
COX-2 240 nM (IC 50 ) |
COX-2-IN-2 shows no COX-1 inhibition even at 100μM.
COX-2-IN-2 has oral ED 50 values of 0.030 and 0.47mg/kg on adjuvant-induced arthritis and collagen-induced arthritis, respectively, and an ED 30 value of 7.4mg/kg in the yeast-induced hyperalgesia (Randall-Selitto) assay. COX-2-IN-2 shows good analgesic activity and no ulcerogenicity.